Airain Ltd’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.73M Buy
44,923
+30,656
+215% +$1.12M 0.08% 298
2017
Q1
$486K Sell
14,267
-16,042
-53% -$527K 0.02% 504
2016
Q4
$994K Buy
+30,309
New +$983K 0.08% 241
2016
Q2
Sell
-23,779
Closed -$712K 716
2016
Q1
$712K Sell
23,779
-4,838
-17% -$134K 0.05% 366
2015
Q4
$792K Buy
+28,617
New +$814K 0.05% 352
2014
Q1
Sell
-27,384
Closed -$726K 745
2013
Q4
$726K Buy
+27,384
New +$762K 0.09% 233

Other funds holding EHC

Airain Ltd's EHC Position: Q2 2017 in Review

Airain Ltd increased its Encompass Health (EHC) stake by 215% in Q2 2017, buying an estimated $1.12M and bringing the position to 44,923 shares worth $1.73M. The position accounts for 0.08% of the portfolio, ranked #298.

Airain Ltd first reported a position in EHC in Q4 2013 and has held it in 6 quarters since. 333 funds tracked by Wall St. Rank hold EHC as of Q2 2017.

  • Airain Ltd held 44,923 shares of Encompass Health worth $1.73M as of Q2 2017.
  • Airain Ltd bought 30,656 Encompass Health shares in Q2 2017, an estimated $1.12M.
  • Encompass Health made up 0.08% of Airain Ltd's portfolio in Q2 2017, its #298 holding.
  • Airain Ltd first reported a position in Encompass Health in Q4 2013 and has held it in 6 quarters since.
  • 333 funds tracked by Wall St. Rank held Encompass Health as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.